Exagen
IPOUnited States · $82.9M raised
- Employees
- 51–200
- Business Model
- B2B
- Website
- exagen.com
- Total Funding
- $82.9M
- Last Round
- $48.0M Series FJan 2015
- Rounds
- 4
About
Diagnostics company providing advanced testing for accurate diagnosis, prognosis, and monitoring of autoimmune conditions for rheumatologists.
Summary
Exagen is a Healthcare company based in United States. It has raised $82.9M in total across 4 rounds, most recently a $48.0M Series F round in Jan 2015. Investors include Innovatus Capital Partners, Cottonwood Technology and EPIC Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2019
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe